Making PROGRESS in stable patients post stroke or transient ischaemic attack: implications for general practice

G Jackson1

  • 1Cardiothoracic Centre, St Thomas' Hospital, London, UK.

Insights

The PROGRESS trial found that perindopril significantly reduces the risk of recurrent stroke, cardiovascular events, and heart failure in patients with a history of stroke or TIA. This blood pressure-lowering treatment is recommended for stable post-stroke patients.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Stroke is a leading cause of death and disability.
  • Survivors face a high risk of subsequent strokes within five years.
  • Effective secondary prevention strategies are crucial.

Purpose of the Study:

  • To evaluate the efficacy of blood pressure lowering with perindopril in preventing recurrent cerebrovascular and cardiovascular events.
  • To assess the impact of perindopril on stroke, cardiovascular events, and heart failure in patients with a history of stroke or transient ischaemic attack (TIA).

Main Methods:

  • The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) was a specific clinical trial.
  • Investigated hypertensive and non-hypertensive patients with prior stroke or TIA.
  • Assessed outcomes with perindopril-based treatment versus placebo.

Main Results:

  • Perindopril significantly reduced the risk of stroke by 28%.
  • Cardiovascular events were reduced by 26% with perindopril treatment.
  • Heart failure incidence decreased by 26% in the perindopril group.

Conclusions:

  • Perindopril offers significant benefits in secondary stroke prevention.
  • Recommended for stable post-stroke patients, potentially combined with indapamide and other evidence-based treatments.
  • Therapy initiation and monitoring can occur in outpatient or general practice settings.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...